Marine Sponge Biomedical Collagen Scaffold Model
Underwrite bioreactor mariculture facilities cultivating marine demosponges to synthesize pharmaceutical-grade fibrillar collagen (providing non-immunogenic, virus-free bio-scaffolds for human tissue engineering and burn grafts). Model medical bio-graft off-take ($1,850/gram), and 20-yr IRR.
1. Capacity & Unit Economics
2. Financial Returns & Yield
$1,850/G MEDICAL BIO-GRAFT COLLAGENAnnual Net EBITDA
$0 / yr
20-Yr Project IRR
0.0%
Gross Revenue
$0 / yr
Total CapEx
$0
Annual OpEx
$0 / yr